Application of prime editing system to introduce TP53 R248Q hotspot mutation in acute lymphoblastic leukemia cell line

Thao Nguyen,Tomomi Aida,Yuka Iijima‐Yamashita,Minori Tamai,Akiko Nagamachi,Keiko Kagami,Chiaki Komatsu,Shin Kasai,Koshi Akahane,Kumiko Goi,Toshiya Inaba,Masashi Sanada,Takeshi Inukai

DOI: https://doi.org/10.1111/cas.16162

IF: 5.7

2024-03-30

Cancer Science

Abstract:The TP53 gene is the most frequently mutated gene in many cancers, and R248Q hotspot mutation of the TP53 gene is reportedly developed in leukemia cells during chemotherapy in a certain population of childhood acute lymphoblastic leukemia (ALL) cases and subsequently results in disease relapse. To directly verify the association of R248Q hotspot mutation of the TP53 gene with chemoresistance in relapsed childhood ALL, we introduced it into the intrinsic TP53 gene of human ALL cell line by applying the prime editing (PE) system, an ideal and versatile genome editing technology, and obtained a subline in which transactivation activity and target gene expression of p53 protein were disrupted and, subsequently, sensitivities to chemotherapeutic agents and irradiation were significantly reduced. Of note, although the acquisition of the designed R248Q mutation as well as the intended additional silent mutation was confirmed as a result of PE in the obtained subline, we additionally noticed previously uncommon editing errors consisting of prime editing guide RNA sequence (part of the scaffold including the 3′ small hairpin structure) and overlapped original genomic DNA sequence, suggesting a requirement of further improvement of the PE system for applying it in cancer research. In childhood acute lymphoblastic leukemia (ALL), TP53 gene mutation is associated with chemoresistance in a certain population of relapsed cases. To directly verify the association of TP53 gene mutation with chemoresistance of relapsed childhood ALL cases and improve their prognosis, the development of appropriate human leukemia models having TP53 mutation in the intrinsic gene is required. Here, we sought to introduce R248Q hotspot mutation into the intrinsic TP53 gene in an ALL cell line, 697, by applying a prime editing (PE) system, which is a versatile genome editing technology. The PE2 system uses an artificial fusion of nickase Cas9 and reverse‐transcriptase to directly place new genetic information into a target site through a reverse transcriptase template in the prime editing guide RNA (pegRNA). Moreover, in the advanced PE3b system, single guide RNA (sgRNA) matching the edited sequence is also introduced to improve editing efficiency. The initially obtained MDM2 inhibitor‐resistant PE3b‐transfected subline revealed disrupted p53 transactivation activity, reduced p53 target gene expression, and acquired resistance to chemotherapeutic agents and irradiation. Although the majority of the subline acquired the designed R248Q and adjacent silent mutations, the insertion of the palindromic sequence in the scaffold hairpin structure of pegRNA and the overlap of the original genomic DNA sequence were frequently observed. Targeted next‐generation sequencing reconfirmed frequent edit errors in both PE2 and PE3b‐transfected 697 cells, and it revealed frequent successful edits in HEK293T cells. These observations suggest a requirement for further modification of the PE2 and PE3b systems for accurate editing in leukemic cells.

oncology